Trogocytosis represents a novel mechanism of action of daratumumab in multiple myeloma

Oncotarget. 2018 Sep 14;9(72):33621-33622. doi: 10.18632/oncotarget.26098.
No abstract available

Keywords: CD38; daratumumab; immunotherapy; multiple myeloma; trogocytosis.

Publication types

  • Editorial